You are viewing a historical snapshot of United States (NYSE / Nasdaq). These figures are a preview to show what TradeTidings covers. Live, continuously updated United States sentiment and stock impact is a Pro feature.
Get live United States data with ProDanaher Corporation (DHR)
7 stories published on DHR since June 2026. See all coverage.
News sentiment trend
Counts of positive, neutral, and negative news items over the last 90 days. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sentiment timeline
How news sentiment on Danaher Corporation (DHR) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
Why this reading
The recent items weighing most on this reading, by direction and influence.
Danaher Stock Tries to Stabilize After a Sharp Post-Earnings Selloff
Direct news · Medium influence · Short term
Danaher's New p-Tau217 Test Adds to Its Alzheimer's Diagnostics Push
Direct news · Medium influence · Long term
Danaher Closes $9.9 Billion Masimo Acquisition, Deepening Patient Monitoring Capabilities
Direct news · Medium influence · Long term
Danaher Stock: DHR's Leica Biosystems Buys StatLab to Expand Pathology Lineup
Direct news · Low influence · Long term
Danaher Stock: DHR's Leica Biosystems Buys StatLab in Pathology Deal
Direct news · Low influence · Long term
Direct news
The most recent stories naming DHR directly, across all of our coverage.
Danaher Stock Tries to Stabilize After a Sharp Post-Earnings Selloff
Danaher Stock: DHR's Leica Biosystems Buys StatLab to Expand Pathology Lineup
Danaher Stock: DHR's Leica Biosystems Buys StatLab in Pathology Deal
Danaher Closes Masimo Healthcare Deal, Capping Strong Med-Tech H1
Danaher Wins CE Mark for Alzheimer's Blood Test, Adding to Diagnostics Lineup
Danaher's New p-Tau217 Test Adds to Its Alzheimer's Diagnostics Push
Danaher Closes $9.9 Billion Masimo Acquisition, Deepening Patient Monitoring Capabilities
Indirect drivers in the news
Macro, commodity, FX and regulatory forces that have moved DHR, with the stories behind each.
No indirect-driver news for DHR in our coverage yet.
Also monitored for DHR (no news in our coverage yet): FDA approvals & trial outcomes, Drug pricing / FDA / IRA.
See the full picture
Sign up free to track DHR, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track DHR for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.